Business Wire5d
Tris Pharma Announces Positive Results from ALLEVIATE-2 Phase 3 Pivotal Trial for Cebranopadol, an Investigational First-in-Class Oral Dual-NMR Agonist, for the Treatment of ...
This dual-NMR agonist has the potential to deliver significant pain relief comparable to opioids with minimized risk of significant side effects, dependence and addiction by leveraging the body ...
Yahoo Finance5d
H World Group Limited (HTHT)
After hours: March 7 at 4:54:04 PM EST Loading Chart for HTHT ...
Yahoo Finance5d
H.B. Fuller Company (FUL)
After hours: March 7 at 5:29:10 PM EST Loading Chart for FUL ...
Bloomberg L.P.5d
CH Robinson Worldwide Inc
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
C&EN6d
Catalyst-Free, Scalable, Green-Light-Mediated Iodoamination, and Further Transformation of Olefins Under Continuous Flow Conditions
Institute of Organic Chemistry, University of Regensburg, 93053 Regensburg, Germany ...